• FDA approves closure device for patent ductus arteriosus

    2 monthes ago - By Healio

    Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management.
    The Amplatzer Piccolo occluder is the first medical device that can be implanted in babies that weigh as little as 2 lb, according to a press release from the company.
    “This approval is a potentially lifesaving advance for the very smallest premature infants that will help us treat these delicate babies who might otherwise not be able to survive,” Evan Zahn, MD, director of the congenital heart program at
    Read more ...